Joining a Clinical Trial for Testicular Cancer

Testicular Cancer Clinical Trials: Benefits, Insurance, and How to Join

Last updated and reviewed on June 28, 2026.

Clinical trials for testicular cancer play a somewhat different role than they do for cancers where current treatments are clearly inadequate. Because testicular cancer already has such high cure rates with established treatments, the goal of most current clinical trials is not to find a treatment that works where nothing else does, but rather to refine treatment, reduce the long-term side effects of cures already achievable, or find better options for the small percentage of patients whose cancer does not respond to standard therapy.

That said, clinical trials remain critically important for certain testicular cancer patients, particularly those with intermediate or poor prognosis disease, those whose cancer has relapsed after standard chemotherapy, and those who are interested in contributing to the research that makes future improvements possible.

Should I Join a Clinical Trial?

Whether a clinical trial makes sense for you depends largely on your specific situation.

• For men with good-prognosis metastatic testicular cancer, standard BEP chemotherapy already achieves cure rates of over 90 percent. In this setting, the primary goal of clinical research is to find ways to get equally good results with less toxicity, for example, by substituting carboplatin for cisplatin or by reducing the number of treatment cycles in carefully selected patients. If such a trial is available to you, participating could give you access to a regimen with fewer side effects while still being treated to a high standard.
• For men with intermediate or poor-prognosis disease, the cure rate with standard BEP chemotherapy, while still meaningful, is lower. Clinical trials in this setting are studying more intensive or novel upfront regimens, including high-dose chemotherapy with stem cell support, immune checkpoint inhibitors, and targeted agents, with the goal of improving on the results achievable with standard treatment. Participating in a trial in this situation may give access to potentially more effective treatment and is worth discussing seriously with your oncologist.
• For men with relapsed or refractory testicular cancer whose cancer has returned after standard chemotherapy, clinical trials are often one of the most important options available. The salvage chemotherapy regimens in current use cure a significant proportion of these patients, but those who relapse again have fewer established options and often the most to gain from accessing experimental treatments in a trial setting.
• For men with Stage I disease who are deciding between surveillance, adjuvant chemotherapy, and RPLND, the evidence base guiding these decisions has been built over decades through clinical trials. Participating in a modern trial comparing these approaches could contribute to the evidence that guides future decision-making.

An important misconception to address: Clinical trials in cancer virtually never give patients a placebo instead of active treatment when an effective treatment exists. In testicular cancer trials, you will always receive at least the current standard of care. Experimental arms compare a new approach against standard treatment or add something new to the standard.

Will My Insurance Cover a Clinical Trial?

Insurance coverage for clinical trial participation is a legitimate and important practical concern. The rules can be complicated, but several important protections exist.

Under the Affordable Care Act (ACA), most private insurance plans and employer-sponsored plans sold in the United States are required to cover the routine costs of care associated with participation in a qualifying clinical trial. Routine care costs are the medical costs you would incur even if you were receiving standard treatment outside of a trial, such as doctor visits, blood tests, imaging, hospitalizations, and treatment for side effects. The experimental drug or device being tested is typically paid for by the trial sponsor, which is usually the National Cancer Institute, a pharmaceutical company, or the institution running the trial.

Medicare has its own clinical trial coverage policy that covers routine costs in qualifying cancer trials. This applies to Medicare Part A (hospital) and Part B (outpatient) coverage. Medicare beneficiaries should confirm their specific plan's coverage with the trial coordinator.

Medicaid coverage of clinical trial costs varies by state, and some states provide broader coverage than others. If you are on Medicaid, ask the trial's research team specifically about coverage in your state.

The most important practical step is to contact your insurance company before enrolling in any trial and ask them specifically what costs related to that trial will be covered. The trial's research coordinator can provide documentation to help with this conversation. Many clinical trial sites also have patient financial advocates who specialize in helping patients navigate insurance questions and identify additional financial assistance if needed.

Some clinical trials also provide reimbursement for travel and lodging costs if the trial site is not near where you live. Ask the research team what financial support they offer for trial participants.

How to Find Testicular Cancer Clinical Trials

Connecting your medical records to HealthTree will match you to a personalized list of clinical trials that you are eligible to participate in.

See My Clinical Trials

Your medical oncologist at a high-volume testicular cancer center is one of the best sources of information about trials currently open that might fit your specific diagnosis, stage, and prior treatment history. Many of the most important testicular cancer trials are conducted through cooperative oncology groups like ECOG-ACRIN or through major academic cancer centers, and your oncologist will know which are currently enrolling.

Sources:

1. National Cancer Institute. Understanding Clinical Trials. https://www.cancer.gov/about-cancer/treatment/clinical-trials/what-are-trials
2. American Cancer Society. What Are Clinical Trials? https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/what-you-need-to-know.html
3. National Institutes of Health. ClinicalTrials.gov. https://clinicaltrials.gov
4. Centers for Medicare and Medicaid Services. Clinical Trials Coverage. https://www.cms.gov/Medicare/Coverage/ClinicalTrialPolicies